USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -463.75 Thousand | -96.89 Thousand |
Net Income | - | - | - | - | -4.49 Million | -4.74 Million |
Depreciation & Amortization | - | - | - | - | 533.33 Thousand | 861.27 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 25.33 Thousand | 85.04 Thousand |
Change in working capital | - | - | - | - | 116.75 Thousand | 330.9 Thousand |
Other non-cash items | - | - | - | - | 3.91 Million | 4.31 Million |
Investing Cash Flow | - | - | - | - | -249.00 | -1.11 Million |
Investments in PPE | - | - | - | - | -249.00 | -1.16 Million |
Acquisitions | - | - | - | - | - | 50 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | 50 Thousand |
Financing Cash Flow | - | - | - | - | 113.7 Thousand | 1.7 Million |
Debt repayment | - | - | - | - | -147.82 Thousand | -25.56 Thousand |
Dividends payments | - | - | - | - | -143.97 Thousand | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 50 Thousand | 1.66 Million |
Other Financing Activities | - | - | - | - | 405.5 Thousand | 1.73 Million |
Accounts receivables | - | - | - | - | -11.47 Thousand | 132.04 Thousand |
Accounts payables | - | - | - | - | 68.44 Thousand | 21.53 Thousand |
Inventory | - | - | - | - | 64.31 Thousand | - |
Other working capital | - | - | - | - | -4530.00 | 177.32 Thousand |
Cash at beginning of period | - | - | - | - | 521.66 Thousand | 30.75 Thousand |
Cash at end of period | - | - | - | - | 171.37 Thousand | 521.66 Thousand |
Capital Expenditure | - | - | - | - | -249.00 | -1.16 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | -350.29 Thousand | 490.91 Thousand |
Free Cash Flow | - | - | - | - | -463.99 Thousand | -1.26 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2017 Q3 | 2017 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -62.5 Thousand | -193.01 Thousand |
Depreciation & Amortization | - | - | - | - | 62.00 | 61.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | -27.76 Thousand | 129.71 Thousand |
Other non-cash items | - | - | - | - | 38.15 Thousand | 61.93 Thousand |
Investing Cash Flow | - | - | - | - | 150 Thousand | -150.00 |
Investments in PPE | - | - | - | - | - | -0.15 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 150.00 | - |
Financing Cash Flow | - | - | - | - | -29.94 Thousand | -25.97 Thousand |
Debt repayment | - | - | - | - | -18.01 Thousand | -16.9 Thousand |
Dividends payments | - | - | - | - | -11.93 Thousand | -9076.00 |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | 7371.00 | -1958.00 |
Accounts payables | - | - | - | - | -29.11 Thousand | 76.04 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | -6014.00 | 55.63 Thousand |
Cash at beginning of period | - | - | - | - | - | 27.48 Thousand |
Cash at end of period | - | - | - | - | 67.94 Thousand | - |
Capital Expenditure | - | - | - | - | - | -0.15 |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 67.94 Thousand | -27.48 Thousand |
Free Cash Flow | - | - | - | - | -52.11 Thousand | -1360.15 |
KTRA
0I8W
BIOE
CPXWF
JETFREIGHT
009180